Sickle cell patient's journey leads to landmark approval of gene-editing treatment

In early December, the Food and Drug Administration approved a gene-editing treatment for sickle cell disease, the first for any illness. One patient helped pave the way.

(Image credit: Orlando Gili for NPR)

from News : NPR https://ift.tt/ahegLGc